Clinical Trial Update: PrOD for Non-Cirrhotic Patients With HCV-1b Receiving Hemodialysis [Phase 4]

View source ↗

Summary

Phase 4 trial update for PrOD in non-cirrhotic patients with hepatitis C genotype 1b on hemodialysis completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• PrOD

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Hepatitis Viruses | Phase 4 | Status: COMPLETED | Results posted: 2019-07-19